# Prostacyclin (PGI2) Pathway to Enhance Wound Healing in Diabetic Foot Ulcers

> **NCT05099367** · NA · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetic Foot

## Interventions

- **DIAGNOSTIC_TEST:** Microdialysis, current induced vasodilation
- **DIAGNOSTIC_TEST:** Skin biopsy
- **DIAGNOSTIC_TEST:** peri-ulcerated skin biopsy

## Key facts

- **NCT ID:** NCT05099367
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05099367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05099367, "Prostacyclin (PGI2) Pathway to Enhance Wound Healing in Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05099367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*